STOCKS TELEGRAPH

Tag: VivoPower stock

  • VivoPower (VVPR) Shares Surge As Takeover Talks Advance With Energi Holdings

    VivoPower (VVPR) Shares Surge As Takeover Talks Advance With Energi Holdings

    As VivoPower International PLC (NASDAQ: VVPR) moves into advanced talks about a possible purchase, the company’s shares have experienced a notable spike. The value of VVPR stock as of the most recent check was $4.25, representing a remarkable 88.06% rise.

    Negotiations with Energi Holdings

    High-level bilateral talks between VivoPower and Energi Holdings Limited (“Energi”) over an unsolicited, non-binding purchase offer have been confirmed. Energi is a well-known energy solutions company with its headquarters in Abu Dhabi. It was established in 2014 and makes about $1 billion a year.

    VVPR has operations throughout the Middle East, Africa, South Asia, Europe, and Southeast Asia, among other places. Targeting all non-affiliated free float shares of VivoPower at an enterprise valuation of US$120 million, the proposed purchase is set up as an all-cash offer.

    However, due diligence is still required before the acquisition can be finalized. By April 2, 2025, both parties have agreed to complete the pricing, terms, and conditions negotiations. Investors have been reassured by its board that further information would be released when it is ready.

    Spin-Off Strategy for Caret Digital

    VivoPower has also revealed plans to spin out Caret LLC (“Caret Digital”), a subsidiary, through a direct listing on the Nasdaq Stock Market, concurrent with its takeover talks. The company has engaged financial advisors to facilitate the process.

    The decision to pursue a direct listing over a reverse merger is driven by considerations of cost-efficiency and expedited execution. Additionally, this approach enables the seamless distribution of dividend shares to VVPR shareholders while avoiding the regulatory complexities associated with a reverse listing via a non-Nasdaq entity.

    Under the proposed terms, shareholders of VivoPower at a designated future record date will be entitled to receive five (5) shares of Caret Digital for each share of VVPR held, with an implied market capitalization of US$250 million.

    Focus on Cryptocurrency Mining and Bitcoin Optimization

    Caret Digital’s strategic direction will center on cryptocurrency mining, specifically Dogecoin (DOGE). VVPR has outlined plans to leverage DOGE mining economics by converting mined DOGE into Bitcoin (BTC) at a discount.

    This approach aims to optimize BTC yields and enhance overall returns. In order to support its growth trajectory, Caret Digital plans to seek $10 million from strategic investors as part of this strategy.

  • Equity Move Sparks Significant Rise In VivoPower (VVPR) Stock

    Equity Move Sparks Significant Rise In VivoPower (VVPR) Stock

    Shares of VivoPower International PLC (NASDAQ: VVPR) have seen a significant increase on the US stock charts today, driven by an announcement regarding an equity move. As of the most recent current-market check, VVPR stock surged by 50.79%, reaching $3.84.

    Amendment and Extension of Shareholder Loan Financing Agreement

    Today, VivoPower International announced that its independent directors have successfully negotiated an amendment and extension to its $34 million shareholder loan financing agreement with the independent directors of its major shareholder, AWN Holdings Limited (“AWN”)

    Under the revised terms, VivoPower has consolidated all of its shareholder loans at the VivoPower International PLC level and reclassified all outstanding loans to non-current status, thereby enhancing the company’s balance sheet profile.

    AWN has also been granted an option to acquire 1,150,000 Tembo shares (the “Options”) from VivoPower following its business combination with Cactus Acquisition Corp, at an exercise price of $1.35 per share. This arrangement supersedes a previous agreement to issue warrants on VivoPower International shares.

    The exercise price reflects the valuation agreed upon by a private investment office backed by a member of the ruling Al Maktoum family of Dubai, as announced in June 2023, considering AWN’s ongoing financial support since 2017.

    The underlying shares to the Option are expected to constitute less than 1.3% of the total estimated shares in the newly listed Tembo post-deSPAC and will be subject to a lock-up period of at least six months.

    Extension of Agreement with Cactus Acquisition Corp

    In another recent development, VivoPower’s electric vehicle subsidiary, Tembo e-LV B.V., announced a one-month extension of its exclusive heads of agreement with Nasdaq-listed Cactus Acquisition Corp to July 31, 2024.

    The purpose of this extension is to give more time for completing the final business combination agreement and securing an impartial fairness assessment. Tembo continues to engage in negotiations with Cactus to conclude the definitive business combination agreement.

  • Significant Stock Surge In VivoPower (VVPR) Amid Merger Update

    Significant Stock Surge In VivoPower (VVPR) Amid Merger Update

    Following the disclosure of a notable update concerning a merger deal involving its subsidiary, VivoPower International PLC (NASDAQ: VVPR) witnessed a significant rise in its shares on the US stock charts. At the latest check during the current market session, VVPR stock had surged by 68.67% to $2.53.

    Extension of Merger Agreement

    VivoPower’s electric vehicle subsidiary, Tembo e-LV B.V., announced a one-month extension of its exclusive heads of agreement with Nasdaq-listed Cactus Acquisition Corporation I, extending the deadline to July 31, 2024. This extension aims to provide additional time to finalize the definitive business combination agreement related to the proposed transaction, as well as to secure an independent fairness opinion. Tembo is actively negotiating with Cactus to conclude the definitive business combination agreement.

    Sale of Non-Core Business Unit

    In a strategic move, VivoPower recently completed the sale of its non-core business unit, Kenshaw Electrical, to ARA Group Limited, a leading diversified industrial services group based in Australia. This follows the April 29 announcement of a definitive asset sale agreement with ARA, with the expected completion date of July 1.

    Expansion of Electric Vehicle Offerings

    VivoPower has secured a minimum order of 200 committed Tembo Tuskers, its fully electric pickup utility vehicle, for delivery to customers and partners in Australia and New Zealand by February 2026. This follows the impressive sales of pickup trucks in Australia in May 2024, amounting to approximately US$700 million, and heightened interest at a leading Australian mining-focused trade show.

    The Tembo Tuskers are available in both left-hand and right-hand drive configurations, with single and dual cab options. They boast a base range of 330 kilometers, a payload capacity of 1 ton, and an unbraked towing capacity of 750 kilograms. Notably, they are priced 15% below other comparable electric utility vehicles in the launch markets of Australia and New Zealand.

    The initial order of Tembo Tuskers is being prepared for delivery to partners and customers in Australia, with full on-road homologation expected by July 2024. Tembo is also seeking to expedite its strategy of introducing the Tuskers to additional markets, including the United Arab Emirates, Africa, Europe, Asia, and Canada.

  • VivoPower (VVPR) Shares Skyrocket: Unraveling The Merger Agreement Impact

    VivoPower (VVPR) Shares Skyrocket: Unraveling The Merger Agreement Impact

    In the current trading session, VivoPower International PLC (NASDAQ: VVPR) shares are witnessing a remarkable upsurge of 271.10%, attaining a valuation of $5.38. This substantial elevation in VVPR shares on the US market can be directly ascribed to the announcement of a merger agreement.

    Tembo, a prominent global entity in utility vehicle electrification and a subsidiary of VivoPower (VVPR), has formally declared its entry into a binding heads of agreement. Pursuant to this agreement, the VivoPower subsidiary will engage exclusively in negotiations to finalize a business combination agreement for merging with Cactus Acquisition Corp. 1 Limited (NASDAQ: CCTS), a special purpose acquisition company (“SPAC”).

    Upon the completion of this business combination, the amalgamated entity is anticipated to retain its listing on NASDAQ under the appellation “Tembo Group.” Concurrent with the completion of the steps outlined in the Business Combination Agreement (BCA), VVPR will pay its stockholders dividends based on a pro rata basis. As of April 30, 2024 (First Record Date), ten percent (10%) of the total Merger Consideration Shares, also known as the “Tembo Dividend Shares,” will be distributed to VivoPower shareholders.

    An additional ten percent (10%) of the aggregate Tembo Dividend Shares will be designated to VivoPower shareholders who were registered on the record date of April 30, 2024, and still retain their VVPR shares as of June 30, 2024 (Second Record Date). These Tembo Dividend Shares will be subject to a lock-up period of six months following the listing of Tembo Group.

    A total of 16.76 million Tembo Dividend Shares, representing 20% of the 83.8 million shares, will be disbursed to VVPR shareholders. Indicatively, VVPR shareholders will receive five Tembo Dividend Shares for each VVPR share they hold, assuming no additional VVPR share issuance or warrant conversions prior to the First Record Date and Second Record Date. The transaction is contingent upon the final execution of a Business Combination Agreement.

    Any remaining cash in CCTS’s Trust account subsequent to the completion of the business combination will be accessible to the surviving entity for operational capital, expansion, and other corporate undertakings. The Business Combination Agreement, inclusive of a fairness opinion, is slated for completion in May 2024, with the transaction targeted to conclude in August 2024.

  • Pre-Market Cues: 30 Stocks Roaring for Change On December 14th

    Sonoma Pharmaceuticals Inc. (SNOA) stock plunged -7.53% to $8.1 in the pre-market trading after reporting partnership with Crown Laboratories to launch Microcyn® technology-based anti-itch over-the-counter products.

    Livent Corporation (NYSE: LTHM) shares are trading up 3.6% at $17.0 at the time of writing. Company’s 52-week ranged between $3.95 to $17.53. Analysts have a consensus price target of $16.50.

    Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) shares are trading down -5.45% at $2.95 at the time of writing after declaring offering of common stock. Company’s 52-week ranged between $1.03 to $5.31.

    NextDecade Corporation (NEXT) is down more than -7.25% at $3.2 in pre-market hours Monday December 14, 2020. The stock had jumped over 38.00% to $3.45 in the last trading session.

    FAT Brands Inc. (FAT) tumbled over -4.06% at $7.57 in pre-market trading today following the announcement from the company that it has entered into an agreement to combine with Fog Cutter Capital Group Inc. (FCCG), the Company’s controlling stockholder.

    Recro Pharma Inc. (REPH) stock soared 3.21% to $3.05 in the pre-market trading. The most recent rating by Stephens, on October 17, 2019, is an Overweight.

    Ampio Pharmaceuticals Inc. (AMPE) stock moved up 3.33 percent to $1.55 in the pre-market trading.

    ReTo Eco-Solutions Inc. (RETO), a Building Materials company, rose about 3.91% at $0.665 in pre-market trading Monday.

    Yiren Digital Ltd. (YRD) lost over -5.36% at $3.0 in pre-market trading Monday December 14, 2020. The firm recently announced that it has entered into two collaborative research agreements to explore new clinical indications for its immunomodulatory drug, Ampion™.

    Before the trading started on December 14, 2020, Sabre Corporation (SABR) is up 3.46% to reach $11.35. It has been trading in a 52-week range of $3.30 to $23.25.

    NantHealth Inc. (NH) is up more than 1.74% at $3.5 in pre-market hours Monday December 14, 2020. The company recently presented during a poster session at the San Antonio Breast Cancer Symposium (SABCS) new significant findings around the adoption of trastuzumab biosimilars in the treatment of HER2-positive breast cancer and the potential clinical and cost benefits of biosimilars. The stock had jumped over 22.42% to $3.44 in the last trading session.

    Torchlight Energy Resources Inc. (TRCH) stock soared 15.79% to $0.88 in the pre-market trading. The most recent rating by ROTH Capital, on March 13, 2020, is a Neutral.

    NIO Limited (NYSE: NIO) shares are trading down -6.38% at $39.3 at the time of writing following the announcement of pricing of offering of 68,000,000 American Depositary Shares. Company’s 52-week ranged between $2.11 to $57.20. Analysts have a consensus price target of $59.

    Lightbridge Corporation (LTBR) is down more than -2.4% at $3.66 in pre-market hours Monday December 14, 2020. The stock had jumped over 12.28% to $3.75 in the last trading session.

    Foresight Autonomous Holdings Ltd. (FRSX) stock moved up 2.31 percent to $1.77 in the pre-market trading after its affiliate, Rail Vision Ltd., has received an order from Knorr-Bremse Systeme für Schienenfahrzeuge GmbH, an affiliate of Knorr-Bremse AG (Frankfurt: KBX), for two samples of their light rail vehicle (LRV) system.

    Before the trading started on December 14, 2020, Hennessy Capital Acquisition Corp. IV (HCAC) is up 2.32% to reach $20.75. It has been trading in a 52-week range of $9.21 to $22.43.

    Inseego Corp. (INSG) stock soared 10.36% to $15.18 in the pre-market trading after reporting that the company is expanding its global footprint in Japan with the launch of its industry-leading 5G MiFi® M2000 mobile hotspot. The most recent rating by ROTH Capital, on August 06, 2020, is a Neutral.

    Mechel PAO (MTL) is down more than -3.66% at $1.84 in pre-market hours Monday December 14, 2020. The stock had jumped over 11.05% to $1.91 in the last trading session.

    JinkoSolar Holding Co. Ltd. (NYSE: JKS) shares are trading up 3.58% at $54.9 at the time of writing after declaring an update to 2020 annual general meeting agenda. Company’s 52-week ranged between $11.42 to $90.20. Analysts have a consensus price target of $55.

    Before the trading started on December 14, 2020, CureVac N.V. (CVAC) is up 6.7% to reach $125.99. It has been trading in a 52-week range of $36.15 to $151.80.

    Xeris Pharmaceuticals Inc. (XERS) grew over 2.84% at $4.7 in pre-market trading today after recent proclamation from company that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive Opinion for Ogluo™ (glucagon).

    Teligent Inc. (NASDAQ: TLGT) shares are trading up 85.54% at $1.17 at the time of writing. Company’s 52-week ranged between $0.46 to $6.46. Analysts have a consensus price target of $2.

    Marathon Patent Group Inc. (MARA) gained over 15.58% at $5.49 in pre-market trading Monday December 14, 2020. The firm recently announced a contract with Bitmain to purchase 10,000 Antminer S-19j Pro ASIC Miners.

    Sundial Growers Inc. (NASDAQ: SNDL) shares are trading up 4.64% at $0.53 at the time of writing after reporting that it has received approval to transfer the listing of its common shares to the Nasdaq Capital Market. Company’s 52-week ranged between $0.14 to $3.88.

    Neos Therapeutics Inc. (NEOS) tumbled over -5.61% at $0.6532 in pre-market trading today. The company and Aytu BioScience, Inc. (AYTU) recently declared that they have entered into a definitive merger agreement pursuant to which Neos will merge with a wholly owned subsidiary of Aytu in an all-stock transaction.

    Arbutus Biopharma Corporation (ABUS), a Biotechnology company, rose about 6.14% at $4.15 in pre-market trading Monday. The healthcare firm lately declared additional clinical data from an ongoing Phase 1a/1b clinical trial (AB-729-001) with AB-729, its proprietary GalNAc delivered RNAi compound.

    Greenwich LifeSciences Inc. (GLSI) lost over -16.07% at $47.0 in pre-market trading Monday December 14, 2020 following the publication of a second poster for the GP2 Phase III clinical trial design for recurring breast cancer at the San Antonio Breast Cancer Symposium (SABCS) in a virtual format.

    Veru Inc. (VERU) is up more than 19.12% at $7.57 in pre-market hours Monday December 14, 2020 following the company revealed positive Phase 2 clinical trial results for enobosarm, for the treatment of endocrine and chemotherapy resistant ER+/HER2- metastatic breast cancer. The stock had jumped over 6.45% to $6.36 in the last trading session.

    NanoVibronix Inc. (NAOV) stock plunged -6.36% to $1.03 in the pre-market trading after reporting that it has expanded and replaced its original distribution agreement with Ultra Pain Products, Inc..

    SELLAS Life Sciences Group Inc. (NASDAQ: SLS) shares are trading down -11.23% at $7.43 at the time of writing following the pricing of $16.2 million registered direct offering. Company’s 52-week ranged between $1.46 to $19.38.